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Objective. The purpose of this study was to assess the effect of high intensity interval training (HIIT) versus continuous aerobic
exercise training (CONT) or placebo (PLA) on body composition by randomized controlled design.Methods. Work capacity and
body composition (dual-energy X-ray absorptiometry) were measured before and after 12 weeks of intervention in 38 previously
inactive overweight adults. Results. There was a significant group × time interaction for change in work capacity (𝑃 < 0.001), which
increased significantly in CONT (23.8 ± 3.0%) and HIIT (22.3 ± 3.5%) but not PLA (3.1 ± 5.0%).There was a near-significant main
effect for percentage trunk fat, with trunk fat reducing in CONT by 3.1 ± 1.6% and in PLA by 1.1 ± 0.4%, but not in HIIT (increase
of 0.7 ± 1.0%) (𝑃 = 0.07). There was a significant reduction in android fat percentage in CONT (2.7 ± 1.3%) and PLA (1.4 ± 0.8%)
but not HIIT (increase of 0.8 ± 0.7%) (𝑃 = 0.04). Conclusion. These data suggest that HIIT may be advocated as a time-efficient
strategy for eliciting comparable fitness benefits to traditional continuous exercise in inactive, overweight adults. However, in this
population HIIT does not confer the same benefit to body fat levels as continuous exercise training.
1. Introduction
Epidemiological data show that themajority of the adult pop-
ulation fails tomeet recommended physical activity levels [1].
This contributes to the global epidemic of overweight/obesity
and associated cardiovascular disease. A reason often cited
for failure to participate in regular exercise is a perceived lack
of time [2].
High intensity interval training (HIIT) could potentially
provide health benefits in a time-efficient manner. This
involves repeated bursts of vigorous exercise interspersed
with low intensity recovery. There is growing evidence from
healthy populations that HIIT leads to a range of cardiovas-
cular and metabolic benefits that are similar to or greater in
magnitude than those achieved with regular continuous aer-
obic exercise. These benefits include increased cardiorespira-
tory fitness [3–9] and work capacity [10], increased muscle
mitochondrial biogenesis and GLUT-4 levels [11], and
improved insulin sensitivity [4, 6, 7]. Relative to the effect
of continuous aerobic exercise, HIIT has also been shown
to induce comparable improvements in fitness and insulin
sensitivity in clinical populations, including those with
overweight/obesity [12–17], cardiovascular disease [18–21],
metabolic syndrome [17], and type 2 diabetes [22–24]. In
some of these studies [7, 21, 23] the benefits of HIIT were
achieved with programs requiring similar training time, but
most found a benefitwith 50–60%of the training time used in
the traditional continuous aerobic exercise comparison group
[3, 5, 8, 16, 18–20].
On the basis of these metabolic and fitness benefits, it
has been argued that HIIT could be used as a time-effective
therapy for the management of body fat levels in overweight
and obese individuals [4, 8, 13, 14, 16, 17, 21, 23, 25–27]. How-
ever, there is currently a dearth of knowledge about the inde-
pendent effects of HIIT on body composition, relative to the
effects of continuous aerobic exercise training. There is some
Hindawi Publishing Corporation
Journal of Obesity
Volume 2014, Article ID 834865, 12 pages
http://dx.doi.org/10.1155/2014/834865
2 Journal of Obesity
evidence that HIIT programs may reduce body mass, trunk
fat, and waist circumference in adolescents and adults [4, 8, 9,
14, 17, 23–27]. However, some of these studies only compared
HIIT with a nonexercising control group [25, 27] or failed
to delineate the independent benefit of HIIT from the con-
founding influence of concurrent continuous training [23,
24] or dietary intervention [14] or employed young, healthy
cohorts [4, 8, 9, 26]. In fact, much of the previous research
showing positive cardiometabolic effects of HIIT was per-
formed in apparently healthy cohorts.These used HIIT inter-
ventions that required repeated 8–30 sec bouts of “all-out”
sprint exercise [4, 8, 13, 15, 26, 27]. Such explosive exercise
is associated with large spikes in plasma adrenalin [28]
and heart rate [27, 28] which may be maintained between 80
and 90% maximum for the duration of the exercise session
[27]. Although perhaps suitable for healthy younger popu-
lations, sprint training is incongruent with the rationale for
using HIIT in a clinical setting for overweight or obese indi-
viduals: not only to gain time-efficient benefits from exercise
but also to avoid risks associated with high workloads [29].
Whilst HIIT programs that are of low risk have been
shown to produce cardiometabolic benefits (improvements
in glycaemic control, insulin sensitivity, and skeletal muscle
oxidative capacity) in peoplewith coronary artery disease and
chronic obstructive pulmonary disease [18–21, 30] or in over-
weight/obese [12, 14] or type 2 diabetes cohorts [22], there
has been no controlled comparison of the independent effect
of HIIT versus that of continuous exercise training on body
composition in these populations for whom an improved
body fat distribution is sought.
We therefore conducted a randomized placebo-
controlled trial to examine the effect of 12 weeks of HIIT
versus continuous aerobic exercise versus a sham-exercise
placebo control on body composition and cardiovascular
risk factors in overweight, previously inactive adults. We
hypothesized that HIIT would improve fitness and reduce
body fat, trunk fat, and android fat and that these benefits
would be comparable to those achieved with traditional
continuous exercise training and could be achieved in
50–60% of the total time.
2. Subjects and Methods
2.1. Participants (Eligibility, Settings, and Locations). 38 inac-
tive (exercising < 3 days/week) and overweight (BMI 25 to
29.9) adult (18- to 55-year-old) men (𝑛 = 7) and women
(𝑛 = 31) were randomized to receive three sessions/week for
12 weeks of regular HIIT, continuous moderate intensity
exercise (CONT), or placebo exercise (PLA) intervention.
Participants were recruited between June 2010 and October
2012 via university noticeboards, electronic bulletins, and
clinical trial databases.The studywas approved by theHuman
Research Ethics Committee of The University of Sydney and
subjects provided written informed consent after obtaining
clearance from amedical practitioner to undertake the study.
Volunteers were excluded if taking lipid-lowering medica-
tion or if they had evidence of any medical disorder not
fully controlled or with varying medications, diabetes, or
hypertension. Two participants were taking antihyperten-
sive medication with the dose unchanged for >12 months.
Medication dose was not altered throughout the study and
compliance was checked verbally each week.
106 individuals were screened by telephone interview
with 38 eligible volunteers undergoing initial assessment and
randomization. Five participants did not complete the pro-
gram (Figure 1). There was no significant difference between
completers and noncompleters and reasons for dropout were
unrelated to the study interventions and classified as “missing
completely at random” [31].Themajority of participants were
Caucasian (𝑛 = 25), with the remainder Asian (𝑛 = 3), Indian
(𝑛 = 2), Arabic (𝑛 = 2), European (𝑛 = 2), West Indian
(𝑛 = 1), South American (𝑛 = 1), and Hispanic (𝑛 = 1).
Volunteers were required to abstain from alcohol, over-
the-counter medication, and strenuous exercise for 24 hours
prior to baseline and postintervention testing. Randomiza-
tionwas undertaken after baseline assessments by equally dis-
tributed pregenerated list (http://www.randomization.com/)
of permuted blocks. Primary outcomes were change in
cardiorespiratory fitness/ work capacity and body fat distri-
bution. Secondary outcomes were anthropometric measures
(body weight, body mass index (BMI), and waist and hip cir-
cumference), blood lipids, serum biochemistry, and resting
blood pressure.
2.2. Cardiorespiratory Fitness/Work Capacity. Cardiorespira-
tory fitness/work capacity was assessed by graded maximal
exercise test on an electronically braked cycle ergometer
(Lode Corival,TheNetherlands) under the supervision of the
study physician. After a 3-minute warm-up at 35W and 65W
for women and men, respectively, intensity was increased by
25W every 150 seconds until volitional fatigue. Heart rate,
blood pressure, and 12-lead ECG were recorded at each stage
of exercise and participants were verbally encouraged to per-
form to volitional fatigue. Rating of perceived exertion (RPE)
was measured using the Borg scale [32]. The test was termi-
nated when the pedalling rate fell below 50 revolutions per
minute or the participant ceased exercise. Peak work capacity
(𝑊peak) was measured [33] and VO2peak estimated [34].
2.3. Body Composition, Anthropometrics, and Blood Pressure.
Total body and regional fat distributions were measured by
dual-energy X-ray absorptiometry (DEXA) (Lunar Prodigy,
GE Medical Systems, Madison, WI, USA, software enCORE
2011 Version 13.60.033). The trunk region included the bot-
tom of the neck line to the top of the pelvis, excluding the
upper limbs.The android region (which incorporates abdom-
inal subcutaneous and visceral adipose tissue) included the
cut of the pelvic region to 20% of the distance between the
pelvic cut and the bottomof the neck line, excluding the arms.
The gynoid measure included the height equal to 2 times the
height of the android region (Lunar enCORE-based X-ray
Bone Densitometry User Manual Revision 6, September
2010). DEXA scanning and analyses were performed by an
individual who was blinded to group allocation. Stature was
measured to the nearest 0.1 cm by stadiometer (Tanita Best
Weight, Seca Model 220, Germany). Waist circumference
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Responded to 
Responders potentially 
eligible and screened by 
telephone interview: 
Screened and randomized:
Randomized 
to HIIT: n = 13
Dropped out: n = 2
(time/availability)
Dropped out: n = 2
(time/availability)
Final completers: 
Randomized to 
CONT: n = 13
Randomized to PLA: 
n = 12
Dropped out: n = 1
(time/availability)
Final completers: n = 11
(M = 2; F = 9)
advertisement: n = 342
n = 106
Eligible: n = 57
Eligible but declined
participation: n = 19
Time commitment: n = 6
Location: n = 2
No reason given: n = 11
n = 11 (M = 3; F = 8)
Final completers: 
n = 11 (M = 2; F = 9)
n = 38 (M = 7; F = 31)
DEXA: n = 10 (M = 2; F = 8)
Figure 1: Flowchart showing the study process.M:male, F: female, HIIT: high intensity interval training, CONT: continuous aerobic exercise,
PLA: placebo control group.
was measured in the horizontal plane, midway between the
inferior margin of the ribs and the superior border of the iliac
crest in deep expiration [33]. Blood pressure was measured
manually from each arm after 10–15 minutes of quiet sitting
with a second reading taken when there was a difference
>10mmHg.
2.4. Blood Sampling and Analysis. Venous blood (8mL) was
collected from the antecubital vein after an overnight fast
(>10 hrs) into 2 serum separation tubes. The whole blood
sample was stored at 4∘C for 2-3 h prior to analysis by an
accredited commercial laboratory (Douglass Hanly Moir Pty
Ltd., Sydney, Australia). Analysis was performed on the same
day as that of collection of serum glucose, insulin and lipids
(including triglycerides (TAG), total cholesterol (TC), high
density lipoprotein cholesterol (HDL-C), and low density
lipoprotein cholesterol (LDL-C)), alanine aminotransferase
(ALT), aspartate aminotransferase (AST), and high sensitiv-
ity C-reactive protein (hs-CRP). The other tube of blood was
used for determination of serum free fatty acids (FFAs).These
tubes were centrifuged at room temperature at 4000 g and
serum was stored at −20∘C before analysis.
Results from the screening visit were used to determine
the presence of metabolic syndrome using the International
Diabetes Federation definition [35].
2.5. Habitual Physical Activity and Dietary Control. Partic-
ipants were asked to maintain their habitual activity and
eating behaviours for the duration of the intervention. Mean
time spent in sedentary time, physical activity, steps per day,
and daily energy expenditure were analysed by a triaxial
accelerometer worn on the upper arm, which also estimated
energy expenditure through galvanic skin response and heat
flux (SenseWear, BodyMedia Inc., PA, USA) for three nonex-
ercising days (two weekdays and one weekend day) during
weeks 1 and 12. Accelerometers were worn for 24 h/day except
during water-based activities such as showering. Participants
also completed a diet diary and subjective physical activity
questionnaire [36] during this period. Diet diaries were
analysed by a dietitian who was blinded to group allocation,
and average daily intake of energy and macronutrients was
quantified by Foodworks (Foodworks 2009, Xyris Software,
v6.0.6502). Accelerometer data were analysed by an assessor
blinded to group allocation and values were averaged over
24 h. Data were omitted from analysis if the monitor was
worn for <90% of a 24-hour period.
2.6. Exercise Intervention. All exercise training in the inter-
vention groups was supervised by an accredited exercise
physiologist. Heart rate, RPE, and blood pressure were
continuously monitored throughout training. Although it
was not possible to be blinded to exercise group allocation,
participants were blinded to the primary purpose of the
study and the placebo group were instructed that the stretch-
ing/massage/fitball intervention was intended to reduce
inflammation and body fat.
High Intensity Interval Training (HIIT).The progressive HIIT
program consisted of repeated bursts of exercise on the
cycle ergometer at a power output designed to elicit 120%
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of VO
2peak. Efforts were interspersed with cycling at a low
intensity (30W). This program was based on interventions
by Little et al. [22] and others [7, 12, 14] which were
undertaken in clinical populations, were well tolerated, and
induced significant improvements in fitness [12, 14, 22] and
insulin sensitivity [12, 22]. For all participants intervals were
progressed over the first four weeks from four intervals
on a work : recovery schedule of 30–45 seconds at 120% of
VO
2peak : 120–180 seconds at low intensity. For weeks 5–12
(i.e., the majority of the intervention period) all partici-
pants performed six intervals on a work : recovery schedule
of 60 : 120 seconds (Table 1). When combined with a six-
minute warm-up/cooldown, total time commitment per
session ranged from 20 to 24minutes. Participants undertook
exercise on three days each week (60 to 72min/week total
training time).
Continuous Endurance Training (CONT). The CONT pro-
gram involved continuous cycling on the ergometer. In
accordance with current recommendations [37], training was
progressed from 30 minutes at an intensity of 50% of VO
2peak
in week one to 45 minutes at an intensity of 65% of VO
2peak
by the fifth week of the study (Table 1). Including warm-
up/cooldown, total time commitment per session ranged
from 36 to 48 minutes. Participants undertook exercise on
three days each week (108 to 144min/week total training
time).
PlaceboGroup (PLA).Participants in the PLAgroupwere pre-
scribed a stretching, self-massage, and fitball program. Par-
ticipants received one fortnightly supervised session which
involved instruction of new exercises to be performed for
two weeks and a 5-minute cycle at very low intensity (30W)
to maintain familiarity with the cycle ergometer. When
combined with home-based sessions, participants in PLA
undertook the sham exercise on three days per week. Dur-
ing the home-based sessions, participants were instructed
towarmup and cool down bywalking slowly for fiveminutes.
Sessions were recorded in a log-book to ensure compliance.
The PLA intervention was designed not to elicit car-
diometabolic improvements but to control for factors such as
attention and participation in a lifestyle intervention.
2.7. Statistics. Compliance was calculated as total number of
sessions attended/total number of sessions available ×100. An
intention-to-treat analysis was employed with group mean
change scores imputed for dropouts. This single imputation
method is valid when data is assumed to be missing com-
pletely at random independent of study intervention and
group allocation [31]. The mean group scores were imputed
for fitness, anthropometry, and blood parameters for the two
dropouts in HIIT and CONT and the one dropout in PLA.
For DEXA, one individual in PLA, who completed all other
measures, did not undergo the final scan and therefore mean
group scores were imputed for two participants in all groups.
The group × time interaction for the change score of all
outcome measures was assessed by analysis of covariance
(ANCOVA) using the baseline value as the covariate (SPSS
version 17.0), with the Bonferroni post hoc comparison used
to locate significant treatment differences. Effect size was
calculated using Hedges’ g corrected for bias with 95% confi-
dence intervals. Relationships between change in android fat
with intervention and change in potential confounders (diet
or nonexercise physical activity time) during treatment were
determined by the Pearson correlation coefficients. Statistical
significance was accepted at 𝑃 < 0.05. Values are reported as
means ± SE.
3. Results
The study population had an average BMI of 28.3±0.3 kg/m2,
total body fat of 42.5±1.1%, andmean age of 42.8±1.4 years.
Other participant characteristics at baseline are described in
Table 2. Thirty-three of the 38 enrolled participants com-
pleted the training and placebo interventions (86%) repre-
senting 11 of 13 individuals (85%) for HIIT, 11 of 13 individuals
(85%) for CONT, and 11 of 12 individuals (92%) for PLA.
Postintervention dietary and habitual physical activity data
were unavailable for some participants (detailed in Table 4).
For individuals who completed the study, compliance with
the exercise intervention was 96%, 92%, and 76% in HIIT,
CONT, and PLA, respectively. There were no adverse events
during testing or training in HIIT or PLA, and there was one
syncopal (fainting) episode during testing in CONT. In the
HIIT sessions systolic blood pressure typically increased by
∼70mmHg from rest during the high intensity intervals and
subsequently reduced by ∼20–30mmHg during the recovery
intervals. Heart rate typically increased by ∼95 beats above
resting during the high intensity intervals and subsequently
reduced by ∼30–40 beats during the recovery intervals. Peak
systolic blood pressure (≤250mmHg) and heart rate (≤90%
HRmax) were maintained at submaximal levels which are
considered suitable for exercise training [38].
3.1. Cardiorespiratory Fitness andWork Capacity. There was a
significant group × time interaction for change in𝑊peak (𝑃 <
0.001), which increased significantly in HIIT (22.3 ± 3.5%)
and CONT (23.8 ± 3.0%) but not PLA (3.1 ± 5.0%) (Table 3).
There was no significant difference in the magnitude of
improvement in𝑊peak between HIIT and CONT (𝑃 = 0.86).
3.2. Body Mass and Body Composition. Body mass did not
change significantly in any group (𝑃 = 0.30) (Figure 2(a))
and there were no significant changes in lean body mass
(Figure 2(b)). There was a significant main effect for total
percentage body fat (𝑃 = 0.049) (Figure 2(c)), with body fat
reducing in CONT (2.6 ± 1.1%) but not HIIT (0.3 ± 0.6%,
𝑃 = 0.02) or PLA (0.7 ± 0.4%, 𝑃 = 0.07). There was a
near-significant main effect for percentage trunk fat (𝑃 =
0.07), which reduced in CONT by 3.1 ± 1.6% and PLA by
1.1±0.4% but not HIIT (increase of 0.7±1.0%) (Figure 3(a)).
The effect of exercise on trunk fat was significantly different
between HIIT and CONT (𝑃 = 0.02). There was a significant
reduction in android fat in CONT (2.7 ± 1.3%) and PLA
(1.4 ± 0.8%) but not HIIT (increase of 0.8 ± 0.6%, 𝑃 =
0.04) (Figure 3(b)). The effect of exercise on android fat was
significantly different between HIIT and CONT (𝑃 = 0.01).
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Table 1: Description of exercise interventions.
Week Frequency Intensity Session duration
Total weekly training time
(including warm-up and
cooldown, min)
Work : recovery Intervals (number)
HIIT
1 3 120%VO2peak: 30W 30 : 180 s 4 60
2 3 120%VO2peak: 30W 30 : 120 s 5 55.5
3 3 120%VO2peak: 30W 45 : 120 s 5 59.25
4 3 120%VO2peak: 30W 45 : 120 s 6 67.5
5–12 3 120%VO2peak: 30W 60 : 120 s 6 72
CONT
1 3 50%VO2peak 30min 108
2 3 60%VO2peak 40min 138
3 3 65%VO2peak 45min 144
4 3 65%VO2peak 45min 144
5–12 3 65%VO2peak 45min 144
HIIT: high intensity interval training; CONT: continuous aerobic exercise; W: watts; VO2peak: peak aerobic capacity.
Table 2: Baseline participant characteristics.
Characteristics PLA(𝑛 = 12)
CONT
(𝑛 = 13)
HIIT
(𝑛 = 13)
Demographics
Age (years) 42.9 (2.8) 44.1 (1.9) 41.8 (2.7)
Sex (𝑛 = M/F) 2/10 2/11 3/10
BMI (kg/m2) 28.2 (0.6) 28.5 (0.6) 28.2 (0.5)
Waist circumference
(cm) 90.9 (3.1) 90.8 (2.1) 92.4 (2.5)
Metabolic syndrome
(Y/N) 2/12 3/13 2/13
Baseline habitual
physical activity
(Bouchard (kJ/Kg/day))
13.8 (0.6) 13.7 (0.4) 13.4 (0.3)
Presented as mean (SE). PLA: placebo; CONT: continuous aerobic exercise;
HIIT: high intensity interval training; M: male; F: female; BMI: body mass
index.
Both HIIT and CONT but not PLA tended to reduce gynoid
fat relative to baseline values, but there was neither any group
× time effect (𝑃 = 0.28) nor any significant difference
between HIIT and CONT (𝑃 = 0.35) (Figure 3(c)).
3.3. Anthropometrics and Blood Pressure. There was no sig-
nificant difference between groups for change in waist or hip
circumference. Neither systolic nor diastolic blood pressure
changed in any group (Table 3).
3.4. Blood Lipids and Biochemistry. There was no significant
group × time interaction for changes in fasting serum AST,
ALT, hs-CRP, triglycerides, HDL-C, insulin, or glucose (𝑃 >
0.05). There was a significant group × time interaction for
total cholesterol and LDL-C (Table 3).
3.5. Habitual Physical Activity and Dietary Control.
Accelerometry data for one participant were omitted
from analysis due to not wearing the accelerometer for the
required period. Another participant refused to wear the
accelerometer and therefore postintervention data for
habitual physical activity and energy expenditure were
available for 𝑛 = 11 in HIIT, 𝑛 = 10 in CONT, and 𝑛 = 10 in
PLA (Table 4). Total energy expenditure, steps taken per day,
time spent in sedentary behaviour, time spent in moderate
physical activity, and self-reported physical activity levels
were not different between groups over time (𝑃 > 0.05)
(Table 4). Diet and physical activity diary data were
unavailable for two participants in HIIT and one participant
in both CONT and PLA. There was no significant group ×
time interaction for any measure of energy or macronutrient
intake as determined by diet diaries or self-reported physical
activity (𝑃 > 0.05) (Table 4).
3.6. Relationship between Change in Body Fat and Other Vari-
ables. Correlations were performed using combined data
from all study participants. Change in android fat was not
significantly correlated with change in daily dietary energy
intake (𝑟 = −0.041, 𝑃 > 0.05) or macronutrient composition
(𝑟 = 0.095, 𝑟 = −0.045, and 𝑟 = 0.177 for percentage carbo-
hydrate, fat, and protein, respectively, 𝑃 > 0.05 for all). There
was no significant correlation between change in android
fat and change in daily energy expenditure (𝑟 = −0.025,
𝑃 > 0.05), sedentary time (𝑟 = 0.002, 𝑃 > 0.05), steps taken
(𝑟 = −0.067), or time spent in incidental moderate activity
(𝑟 = 0.083, 𝑃 > 0.05).
4. Discussion
This is the first study to examine the efficacy of HIIT versus
that of continuous aerobic exercise training on body fat
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Table 4: Habitual energy intake and energy expenditure.
PLA CONT HIIT 𝑃
Baseline Postintervention Baseline Postintervention Baseline Postintervention
Energy intake
Fat (g/day) 92 (11) 78 (8) 101 (12) 87 (8) 86 (11) 79 (11) 0.80
% intake 32 (3) 30 (1) 35 (2) 34 (1) 33 (3) 33 (2) 0.98
Carbohydrate (g/day) 265 (21) 238 (14) 268 (23) 252 (22) 227 (13) 209 (20) 0.28
% intake 43 (2) 42 (2) 43 (3) 42 (2) 41 (2) 41 (2) 0.80
Protein (g/day) 116 (10) 111 (13) 108 (10) 98 (10) 103 (11) 95 (8) 0.67
% intake 20 (1) 20 (2) 17 (1) 18 (1) 19 (1) 19 (1) 0.46
Total energy intake
(kJ/day) 10319 (893) 9283 (578) 10523 (917) 9527 (830) 9403 (776) 8190 (867) 0.44
Energy expenditure
Total energy
expenditure (kJ/day) 10354 (609) 9990 (557) 10527 (462) 9989 (521) 10414 (368) 10506 (450) 0.58
Steps/day 9897 (1271) 7243 (1240) 9740 (1036) 8374 (956) 9212 (820) 8989 (890) 0.42
Sedentary time, <3
METS (hours/day) 20:19 (0:58) 18:57 (1:31) 21:51 (0:11) 20:54 (1:09) 20:47 (0:41) 21:27 (0:01) 0.11
Moderate activity,
3–6 METS (hours/day) 1:29 (0:13) 1:17 (0:15) 1:25 (0:12) 1:13 (0:13) 1:31 (0:07) 1:41 (0:01) 0.57
Total self-reported energy
expenditure (Bouchard
score, kJ/Kg/day)
13.8 (0.6) 14.2 (0.8) 13.7 (0.4) 13.7 (0.4) 13.4 (0.3) 13.6 (0.4) 0.79
Presented as mean (SE). PLA: placebo; CONT: continuous aerobic exercise; HIIT: high intensity interval training; METS: metabolic equivalents, 𝑛 = 12/13/13
for PLA/CONT/HIIT, respectively, at baseline, 𝑛 = 9/10/10 for PLA/CONT/HIIT, respectively, at postintervention testing for energy intake, 𝑛 = 10/10/11
in PLA/CONT/HIIT, respectively, at postintervention testing for energy expenditure, and 𝑛 = 9/10/10 in PLA/CONT/HIIT, respectively, at postintervention
testing for total self-reported energy expenditure.
levels in previously inactive, overweight adults for whom an
improved fat distribution is sought. Using a 12-week random-
ized placebo-controlled design, we showed thatHIIT resulted
in a similar improvement in work capacity to that induced
by continuous aerobic exercise in this cohort. Moreover, the
HIIT-induced improvement in fitness was achieved in only
∼50–60% of the time taken for the same gain in fitness via
continuous aerobic exercise (60–72 versus 108–144 minutes
per week). However, although HIIT has been suggested to
be effective for the management of body fat levels [4, 8, 13,
14, 16, 17, 21, 23, 25–27], we have provided the first direct
evidence that continuous aerobic exercise, but not HIIT,
reduces total body fat and android fat in previously inactive,
overweight adults. We thus conclude that while HIIT is a
time-effective means of achieving improved fitness, it should
not be promoted as a time-effective means of increasing fat
loss and improving fat distribution for this population.
Our demonstration that HIIT induced a similar improve-
ment in fitness to that of continuous aerobic exercise confirms
recent reports which have examined the effect of HIIT on
cardiorespiratory fitness in a range of populations [3, 4,
13, 22]. It also demonstrates that a regime involving 1min
bursts at ∼maximal capacity and taking approximately 50–
60% of the training time of the continuous exercise program
is safe and effective. Given that aerobic fitness is a potent
independent predictor of health and mortality [39], this
finding provides evidence for utilising HIIT as part of the
management of cardiometabolic risk in previously inactive
and overweight populations. However, excess deposition of
body fat, particularly abdominal fat (which includes visceral
adipose tissue), is also recognized as being an independent
risk factor for insulin resistance [40], cardiovascular disease
[41], and death [42], and small differences in visceral adipose
tissue area/volume can significantly alter risk profile [43].
Whilst the recent interest in HIIT has led to the suggestion
that it may be useful for beneficial body composition change
in overweight/obesity, there is a paucity of quality evidence
to support this, and no randomized placebo-controlled trials
in overweight cohorts have been undertaken. The clear lack
of benefit of HIIT to body fat levels observed in the cur-
rent study suggests that emphasizing HIIT over continuous
exercise for the specific management of body fat levels in
previously inactive, overweight individuals is unfounded.
Until contrary evidence from randomized controlled studies
is available, the current findings imply a need to reemphasise
the importance of traditional continuous aerobic exercise in
higher volumes which, as corroborated in the present study,
has a proven ability to improve fat partitioning even in the
absence of weight loss [44].
To avoid risk of cardiovascular and musculoskeletal
events during training we chose a HIIT protocol that is likely
to involve less risk for overweight previously sedentary people
than that of an “all-out” sprinting protocol. HIIT protocols
can vary in exercise intensity, timing of the work : recovery
cycles, type and intensity of recovery, and the number of
intervals, making comparison between studies problematic.
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Figure 2: Effect of 12 weeks of high intensity interval training
(HIIT) or continuous aerobic exercise (CONT) or control (PLA) on
relative percent change in (a) body mass, (b) total lean mass, and
(c) total body fat. Circles show individual percentage change from
baseline and horizontal bars show mean group percentage change
from baseline. Values are means ± SE; 𝑛 = 13 for HIIT, 𝑛 = 13
for CONT, and 𝑛 = 12 for PLA. †Significant treatment × time
interaction (𝑃 < 0.05). ∗Significant difference between CONT and
HIIT (𝑃 < 0.05).
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Figure 3: Effect of 12weeks of high intensity interval training (HIIT)
or continuous aerobic exercise (CONT) or control (PLA) on relative
percent change in (a) trunk fat, (b) android fat, and (c) gynoid
fat. Circles show individual percentage change from baseline and
horizontal bars show mean group percentage change from baseline.
Values are means ± SE; 𝑛 = 13 for HIIT, 𝑛 = 13 for CONT, and
𝑛 = 12 for PLA. †Significant treatment× time interaction (𝑃 < 0.05).
∗Significant difference between CONT and HIIT (𝑃 < 0.05).
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However, generally in clinical populations (e.g., coronary
artery disease, chronic obstructive pulmonary disease, type
2 diabetes, and chronic heart disease), HIIT programs use
60–240-second efforts of near-maximal or maximal aerobic
exercise, with interspersed recovery periods, and have been
shown to elicit a range of cardiovascular and metabolic ben-
efits but with cardiovascular strain minimised [19–21]. For
instance, in overweight [12], obese [14], and type 2 diabetes
cohorts [22], 60-second bouts of exercise at near-maximal
capacity, with 60–120-second recovery periods, led to signifi-
cant improvements in glucose control [22], insulin sensitivity
[12, 22], and skeletal muscle oxidative capacity [22]. However
in all but one of these studies [14], no continuous aerobic
exercise control or placebo control was included. Given our
previously inactive overweight adult cohort, we employed a
similar work : recovery cycle of 60 : 120 seconds. Although
all participants reported maximal to near-maximal perceived
exertion (BorgRPE 18–20) during thework phase, peak blood
pressure (systolic blood pressure ≤ 250mmHg) and heart
rate (≤90%maximal heart rate) were within normal limits for
exercise [38], and the protocol was well tolerated by partici-
pants with no adverse events. We acknowledge the need to
further investigate the efficacy of HIIT interventions on fat
distribution in overweight cohorts using a range of HIIT
protocols.
It is now well established that regular exercise can lead
to preferential fat, including visceral fat reduction (even
in the absence of weight loss). Aerobic exercise signifi-
cantly increases hormone-stimulated adipose lipolysis and
subsequent circulating fatty acid availability, which when
combinedwith the sustained increase inmetabolic rate (VO
2
)
results in increased uptake and oxidation of fatty acids in
working muscle [45]. Although the precise mechanism of
preferential fat reduction remains unclear, visceral adipose
tissue lipolysis is believed to be particularly sensitive to these
hormonal changes [46]. As acute bouts of sprint-like HIIT
significantly increase the catecholamines (epinephrine and
norepinephrine) and growth hormone, which stimulate lipol-
ysis [28, 47, 48], it has been suggested that HIIT may be
effective for visceral fat reduction [49]. In the absence of
supporting physiological data it is difficult to speculate on the
mechanism explaining the effectiveness and lack thereof of
the continuous and HIIT interventions, respectively, in the
current study. However, taken together, the aforementioned
effects may imply that mere elevation of lipolysis and fatty
acid availability via HIIT does not necessarily translate into
a significant increase in fatty acid oxidation and ultimately
fat loss.This may be because the total amount of fat oxidation
(during and after exercise), which is a function of fatty acid
availability, metabolic rate, and duration of exercise, may
still be lower in HIIT than in traditional prolonged aerobic
exercise.
We acknowledge that the small sample size in this study
(38 enrolled, 33 completed) limits the ability to draw some
conclusions about the relative potency of CONT versus
that of HIIT from our trial. This affects the majority of
studies in this area, as compliance with specific exercise
interventions requires intensive supervision. Similarly it is
difficult to definitively exclude the impact that changes in
lifestyle, outside of the exercise intervention, can have on
body fat outcomes in this type of research. For example
there was a small reduction of android fat in PLA, and
such changes are common in clinical trials under free living
conditions where participants may alter their behaviour [50].
However, in our study the changes observed in the exercise
interventions arguably reflect the effect of the interventions
per se because there were no significant differences in dietary
intake and nonexercise physical activity detected, nor were
any correlations observed between these and loss of android
fat. Lastly, themajority of our cohort were Caucasian females,
and there were only a small number of males (𝑛 = 5) and
a small number of people from other ethnic backgrounds.
This increases the variance in our cohort and also may limit
generalization of the results. Therefore, whilst our study has
provided important first data comparing HIIT versus con-
tinuous aerobic exercise versus placebo in fitness and body
composition in previously inactive and overweight adults,
more studies are warranted in similar cohorts.
Overall, the results from this study show that continuous
aerobic exercise training is effective for improving fat dis-
tribution independently of weight loss, but the HIIT inter-
vention employed did not improve fat distribution. However,
despite using 50–60% of the total training time employed in
the CONT intervention, HIIT significantly improved work
capacity in previously inactive and overweight adults.
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